Verition Fund Management »

Y Mabs Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $270k 17k 16.26

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Polar Capital Holdings
Point72 Asset Management
D. E. Shaw & Co
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Y Mabs Therapeutics